Critical Outcome Technologies Inc. Share Price Other OTC
Equities
CA22675B1031
Biotechnology & Medical Research
Sales 2018 | - | Sales 2019 | - | Capitalization | 1.61M 126M |
---|---|---|---|---|---|
Net income 2018 | -4M -312M | Net income 2019 | -2M -156M | EV / Sales 2018 | - |
Net cash position 2018 | 40.73K 3.18M | Net cash position 2019 | 24.64K 1.92M | EV / Sales 2019 | - |
P/E ratio 2018 |
-1.11
x | P/E ratio 2019 |
-0.6
x | Employees | - |
Yield 2018 * |
-
| Yield 2019 |
-
| Free-Float | 69.18% |
Managers | Title | Age | Since |
---|---|---|---|
Alison D. Silva
PSD | President | 46 | 31/12/14 |
Debi Sanderson
COO | Chief Operating Officer | - | - |
Chief Tech/Sci/R&D Officer | 61 | 11/06/17 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 63 | 30/06/18 | |
John C. Drake
CHM | Chairman | - | 19/02/07 |
Alison D. Silva
PSD | President | 46 | 31/12/14 |
1st Jan change | Capi. | |
---|---|---|
+18.72% | 123B | |
+14.53% | 107B | |
-2.88% | 24.01B | |
+2.18% | 22.59B | |
-10.09% | 18.16B | |
-41.04% | 16.84B | |
-11.83% | 16.23B | |
+1.46% | 13.43B | |
+24.22% | 11.32B |